Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study

References

• Fock KM, Graham DY, Malfertheiner P. Helicobacter pylori research: historical insights and future directions. Nat Rev Gastroenterol Hepatol. 2013;10:495–500. doi:10.1038/nrgastro.2013.96
   PubMed Web of Science ®Google Scholar
• Wu MS, Lee WJ, Wang HH, et al. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med. 2005;165:1552–1555. doi:10.1001/archinte.165.13.1552
   PubMedGoogle Scholar
• Alboraie M, Elhossary W, Aly OA, et al. Egyptian recommendations for management of Helicobacter pylori infection: 2018 report. Arab J Gastroenterol. 2019;20(3):175–179. doi:10.1016/j.ajg.2019.09.001
   PubMed Web of Science ®Google Scholar
• Shehata MA, Talaat R, Soliman S, et al. Randomized controlled study of a novel triple nitazoxanide (NTZ)-containing therapeutic regimen versus the traditional regimen for eradication of Helicobacter pylori infection. Helicobacter. 2017;22(5):e12395. doi:10.1111/hel.2017.22.issue-5
   Google Scholar
• Cizginer S, Ordulu Z, Kadayifci A. Approach to Helicobacter pylori infection in geriatric population. World J Gastrointest Pharmacol Ther. 2014;5:139–147. doi:10.4292/wjgpt.v5.i3.139
   PubMedGoogle Scholar
• Abd-Elsalam S, Kobtan A, El-Kalla F, et al. A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience. Medicine (Baltimore). 2016;95(24):e3879. doi:10.1097/MD.0000000000003879
   PubMedGoogle Scholar
• Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13:2–9. doi:10.1111/j.1751-2980.2011.00550.x
   PubMed Web of Science ®Google Scholar
• Waluga M, Kukla M, Żorniak M, et al. From the stomach to other organs: Helicobacter pylori and the liver. World J Hepatol. 2015;18(7):2136–2146. doi:10.4254/wjh.v7.i18.2136
   Google Scholar
• Bellentani S, Scaglioni F, Marino M, et al. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010;28:155–161. doi:10.1159/000282080
   PubMed Web of Science ®Google Scholar
• Doğan Z, Filik L, Ergül B, et al. Association between Helicobacter pylori and liver-to-spleen ratio: a randomized-controlled single-blind study. Eur J Gastroenterol Hepatol. 2013;25:107–110. doi:10.1097/MEG.0b013e3283590c10
   PubMed Web of Science ®Google Scholar
• Takuma Y. Helicobacter pylori infection and liver diseases. Gan to Kagaku Ryoho. 2011;38:362–364.
   PubMedGoogle Scholar
• Polyzos SA, Kountouras J, Papatheodorou A, et al. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism. 2013;62:121–126. doi:10.1016/j.metabol.2012.06.007
   PubMed Web of Science ®Google Scholar
• Taylor NS, Fox JG, Yan L. In-vitro hepatotoxic factor in Helicobacter hepaticus, H. pylori and other Helicobacter species. J Med Microbiol. 1995;42:48–52. doi:10.1099/00222615-42-1-48
   PubMed Web of Science ®Google Scholar
• Fukuda Y, Bamba H, Okui M, et al. Helicobacter pylori infection increases mucosal permeability of the stomach and intestine. Digestion. 2001;63(1):93–96. doi:10.1159/000051918
   PubMedGoogle Scholar
• Polyzos SA, Kountouras J, Zavos C, et al. The association between Helicobacter pylori infection and insulin resistance: a systemic review. Helicobacter. 2011;16(2):79–88. doi:10.1111/j.1523-5378.2011.00822.x
   PubMed Web of Science ®Google Scholar
• Khoshbaten M, Baghaei K, Bafandeh Y, et al. The role of Helicobacter pylori and CagA in response to treatment in Iranian gastroesophageal reflux diseases patients. Gastroenterol Hepatol Bed Bench. 2013;6:S93–8.
   PubMedGoogle Scholar
• Mansour L, El-Kalla F, Kobtan A, et al. Helicobacter pylori may be an initiating factor in newly diagnosed ulcerative colitis patients: A pilot study. World J Clin Cases. 2018;6(13):641–649. doi:10.12998/wjcc.v6.i13.641
   PubMedGoogle Scholar
• Salama RI, Emara MH, Mostafa HM, et al. Helicobacter pylori infection and risk of salmonella infection. Medicine (Baltimore). 2019;98(6):e14335. doi:10.1097/MD.0000000000014335
   PubMedGoogle Scholar
• Sumida Y, Kanemasa K, Imai S, et al. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease. J Gastroenterol. 2015;50:996–1004. doi:10.1007/s00535-015-1039-2
   PubMed Web of Science ®Google Scholar
• Okushin K, Takahashi Y, Yamamichi N, et al. Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan. BMC Gastroenterol. 2015;15(1):25. doi:10.1186/s12876-015-0247-9
   PubMedGoogle Scholar
• Baeg MK, Yoon SK, Ko SH, et al. Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease. World J Gastroenterol. 2016;22(8):2592–2600. doi:10.3748/wjg.v22.i8.2592
   PubMedGoogle Scholar
• Fan N, Peng L, Xia Z, et al. Helicobacter pylori infection is not associated with non-alcoholic fatty liver disease: a cross-sectional study in China. Front Microbiol. 2018;1(9):73. doi:10.3389/fmicb.2018.00073
   Google Scholar
• Xu C, Yan M, Sun Y, et al. Prevalence of Helicobacter pylori infection and its relation with body mass index in a Chinese population. Helicobacter. 2014;19:437–442. doi:10.1111/hel.2014.19.issue-6
   PubMed Web of Science ®Google Scholar
• Kim TJ, Sinn DH, Min YW, et al. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease. J Gastroenterol. 2017;52:1201–1210. doi:10.1007/s00535-017-1337-y
   PubMedGoogle Scholar
• Akbas HS, Basyigit S, Suleymanlar I, et al. The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects. Lipids Health Dis. 2010;9:92. doi:10.1186/1476-511X-9-92
   PubMed Web of Science ®Google Scholar
• Ryan CK, Johnson LA, Germin BI, et al. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl. 2002;8:1114–1122. doi:10.1053/jlts.2002.36740
   PubMed Web of Science ®Google Scholar
• Shannon A, Alkhouri N, Carter-Kent C, et al. Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr. 2011;53:190–195. doi:10.1097/MPG.0b013e31821b4b61
   PubMed Web of Science ®Google Scholar
• Mantovania A, Turinoa T, Altomaria A, et al. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: an updated meta-analysis. Metabolism. 2019;96:56–65. doi:10.1016/j.metabol.2019.04.012
   PubMedGoogle Scholar
• Ning L, Liu R, Lou X, et al. Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systemic review and meta-analysis. Eur J Gastroenterol Hepatol. 2019;31(7):735–742. doi:10.1097/MEG.0000000000001398
   PubMedGoogle Scholar
• Chen C, Zhang C, Wang X, et al. Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. Eur J Gastroenterol Hepatol. 2019; 1. doi:10.1097/MEG.0000000000001601.
   PubMedGoogle Scholar